Objective: The 2017 PhysioNet/CinC Challenge focused on automatic classification of atrial fibrillation (AF) in short ECGs. This study aimed to evaluate the use of the data and results from the challenge for detection of AF in longer ECGs, taken from three other PhysioNet datasets.
Approach: The used data-driven models were based on features extracted from ECG recordings, calculated according to three solutions from the challenge. A Random Forest classifier was trained with the data from the challenge. The performance was evaluated on all non-overlapping 30 s segments in all recordings from three MIT-BIH datasets. Fifty-six models were trained using different feature sets, both before and after applying three feature reduction techniques.
Main Results: Based on rhythm annotations, the AF proportion was 0.00 in the MIT-BIH Normal Sinus Rhythm (N = 46083 segments), 0.10 in the MIT-BIH Arrhythmia (N = 2880), and 0.41 in the MIT-BIH Atrial Fibrillation (N = 28104) dataset. For the best performing model, the corresponding detected proportions of AF were 0.00, 0.11 and 0.36 using all features, and 0.01, 0.10 and 0.38 when using the 15 best performing features.
Significance: The results obtained on the MIT-BIH datasets indicate that the training data and solutions from the 2017 Physionet/Cinc Challenge can be useful tools for developing robust AF detectors also in longer ECG recordings, even when using a low number of carefully selected features. The use of feature selection allows significantly reducing the number of features while preserving the classification performance, which can be important when building low-complexity AF classifiers on ECG devices with constrained computational and energy resources.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1088/2057-1976/ab6e1e | DOI Listing |
Importance: Cardiovascular health outcomes associated with noncigarette tobacco products (cigar, pipe, and smokeless tobacco) remain unclear, yet such data are required for evidence-based regulation.
Objective: To investigate the association of noncigarette tobacco products with cardiovascular health outcomes.
Design, Setting, And Participants: This cohort study was conducted within the Cross Cohort Collaboration Tobacco Working Group by harmonizing tobacco-related data and conducting a pooled analysis from 15 US-based prospective cohorts with data on the use of at least 1 noncigarette tobacco product ranging between 1948 and 2015.
J Gen Intern Med
January 2025
Northwell, 2000 Marcus Ave., Suite 300, New Hyde Park, NY, 11042-1069, USA.
Egypt Heart J
January 2025
Department of Cardiology, Lianyungang No 1 People's Hospital, No. 6 East Zhenhua Road, Haizhou District, Lianyungang, 222061, Jiangsu, China.
Background: The rate at which atrial fibrillation (AF) patients experience a return of symptoms after catheter ablation is significant, and there are multiple risk factors involved. This research intends to perform a meta-analysis to explore the risk factors connected to the recurrence of AF in patients following catheter ablation.
Methods: The PubMed, Cochrane Library, WOS, Embase, SinoMed, CNKI, Wanfang, and VIP databases were explored for studies from January 1, 2000 to August 10, 2021, and research meeting the established inclusion requirements was chosen.
Curr Cardiol Rep
January 2025
Third Department of Medicine, General University Hospital and First Faculty of Medicine, Charles University, 121 08, Prague, Czech Republic.
Purpose Of Review: In recent years, the terms "metabolic associated fatty liver disease-MAFLD" and "metabolic dysfunction-associated steatotic liver disease-MASLD" were introduced to improve the encapsulation of metabolic dysregulation in this patient population, as well as to avoid the negative/stigmatizing terms "non-alcoholic" and "fatty".
Recent Findings: There is evidence suggesting links between MASLD and coronary heart disease (CHD), heart failure (HF), atrial fibrillation (AF), stroke, peripheral artery disease (PAD) and chronic kidney disease (CKD), although the data for HF, AF, stroke and PAD are scarcer. Physicians should consider the associations between MASLD and CV diseases in their daily practice.
J Cardiovasc Electrophysiol
January 2025
Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.
Ryanodine receptor 2 (RyR2) protein, a calcium ion release channel in the sarcoplasmic reticulum (SR) of myocardial cells, plays a crucial role in regulating cardiac systolic and diastolic functions. Mutations in RyR2 and its dysfunction are implicated in various congenital heart diseases (CHDs). Studies have shown that mutations in the RYR2 gene, which encodes the RyR2 protein, are linked to several cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT syndrome (LQTS), calcium release deficiency syndrome (CRDS), and atrial fibrillation (AF).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!